Physician profile
Daniel J Kanzer
NPI 1083145106
$5,860.66
in general payments reported to CMS, 2019-2025
11 companies · $982 in 2025
The $982 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,434 · 2023: $788 · 2024: $1,656 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719 · Consulting Fee: $450 · Travel and Lodging: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.09 |
| Consulting Fee | $450.00 |
| Travel and Lodging | $257.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,383.41 | 2022-2023 | Proclaim, Prodigy |
| Nalu Medical, INC. | $1,106.83 | 2023-2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $724.93 | 2023-2025 | Sprint Pns System |
| Nevro Corp. | $631.76 | 2023-2024 | Senza |
| Globus Medical, INC. | $304.21 | 2025 | Senza |
| Boston Scientific Corporation | $218.50 | 2022-2024 | Intracept |
| Ge Healthcare | $149.76 | 2024 | |
| Medtronic, INC. | $141.64 | 2022-2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $107.25 | 2025 | |
| Horizon Therapeutics Plc | $72.02 | 2022 | |
| Abbvie INC. | $20.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kanzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.